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Membrane cholesterol regulates LFA-1 function and lipid raft heterogeneity
Muhammad Reza Marwali, Jose Rey-Ladino, Lisa Dreolini, Douglas Shaw, and Fumio Takei
Many surface receptors and signaling
molecules are thought to associate with
unique membrane microdomains termed
lipid rafts. We examined the involvement
of lipid rafts in the activation of leukocyte
function–associated antigen-1 (LFA-1).
Depletion or sequestration of cholesterol
with methyl--cyclodextrin (MCD) or ﬁli-
pin, respectively, strongly inhibited
LFA-1–mediated adhesion of T-cell lines
and primary T cells. This inhibition was
reversed by cholesterol reconstitution.
LFA-1 on T-cell lines was detected in cold
Triton X-100–insoluble lipid rafts, which
were disrupted by MCD or ﬁlipin treat-
ment. However, no LFA-1 on primary T
cells was detected in lipid rafts isolated
by the same procedures, and these rafts
were resistant to cholesterol depletion or
sequestration. Association of LFA-1 with
lipid rafts of primary T cells could be
detected only when they were isolated
with another nonionic detergent, Brij 35.
Upon treatment with MCD, LFA-1 in Brij
35–insoluble lipid rafts partially shifted to
nonraft fractions. T-cell lines were found
to have a high level of cholesterol and a
low level of ganglioside GM1, a common
marker for lipid rafts, whereas primary T
cells have a much lower level of choles-
terol and a very high amount of GM1.
Cross-linking of LFA-1 on primary T cells
induced cocapping of cholesterol but not
GM1. These results suggest that lipid
rafts of T cells are heterogenous, and
LFA-1 associates with a subset of lipid
rafts containing a high level of choles-
terol. This association seems to regulate
LFA-1 functions, possibly by facilitating
LFA-1 clustering. (Blood. 2003;102:
215-222)
© 2003 by TheAmerican Society of Hematology
Introduction
Leukocyte function–associated antigen-1 (LFA-1) (L2; CD11a/
CD18) is a member of the leukocyte integrin family and consists of
a 180-kDa -chain (CD11a or L) and a 95-kDa -chain (CD18 or
2).1 It plays a critical role in the inﬂammation process. Chemo-
kines released during inﬂammation activate LFA-1 to mediate ﬁrm
adhesion of leukocytes to endothelial cells and induce their
migration and extravasation from the blood vessel.2 Binding of
LFA-1 on T cells to its ligand intercellular adhesion molecule-1
(ICAM-1) has been shown to provide a second signal for T-cell
activation.3 LFA-1 also participates in immune responses by
forming an immunologic synapse together with T-cell receptors
(TCRs) and other costimulatory molecules when T cells interact
with antigen-presenting cells.4-6
Although resting leukocytes constitutively express LFA-1, they
do not readily adhere to cells expressing its ligands, as the adhesive
functions of LFA-1 are regulated by cell activation. Through the
process of inside-out signaling, intracellular activation signals
convert low-avidity LFA-1 on resting leukocytes into an active
form capable of mediating cell adhesion. This conversion does not
require an increase in the cell-surface expression of LFA-1.1,7 The
prevailing theories to explain this phenomenon are that LFA-1
undergoes a conformational change upon cell activation or that
LFA-1 is redistributed at the cell surface.8,9 Evidence for the former
comes from the existence of antibodies that recognize epitopes on
activated LFA-1.10-13 Other studies suggest that clustering of LFA-1
leading to multivalent interaction between LFA-1 and ICAM-1
may be important.14,15
Lipid rafts are highly organized microdomains of the plasma
membrane. They have a high content of cholesterol, gangliosides,
sphingolipids, and phospholipids with long saturated fatty acyl
chains, and they are resistant to extraction with cold nonionic
detergents.Lipidraftsareisolatedasdetergent-insolubleglycolipid-
enriched membranes in low-density fractions of sucrose gradient
centrifugation.16 Molecules such as glycosylphosphatidylinositol
(GPI)–anchored proteins and acylated proteins are known to
partition into lipid rafts. Cholesterol plays an important role in
maintaining lipid rafts in a liquid-ordered phase, whereas the rest of
the membrane that contains phosphatidyl ethanolamine and phos-
phatidyl choline combined with lesser amounts of cholesterol
exists in a liquid-disordered phase. Depletion of cholesterol by
methyl--cyclodextrin (MCD) or sequestering cholesterol out of
lipid rafts by ﬁlipin is commonly used to disrupt lipid rafts.17 Many
cell-surface receptors and intracellular signaling proteins are
thought to localize in lipid rafts. However, direct visualization of
these molecules in lipid rafts is difﬁcult because they are thought to
be only 50 to 100 nm in diameter, which is below the resolution of
optical microscopes.18,19 Therefore, the detection of receptors and
signaling molecules in the low-density fractions of sucrose gradient
centrifugation combined with raft-disrupting reagents such as
MCD and ﬁlipin is often used to determine the localization of
receptors in lipid rafts. Cross-linking of various cell-surface
receptors can induce fusion of lipid rafts to form clusters large
enough to be visible by ﬂuorescence microscope upon staining
with ﬂuorescence-conjugated cholera toxin subunit B (CTxB),
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215 BLOOD, 1 JULY 2003 VOLUME 102, NUMBER 1which binds to ganglioside GM1. Colocalization of molecules with
GM1 may be used as an indication that the molecules associate
with lipid rafts. However, recent studies have suggested heteroge-
neity among lipid rafts. In human peripheral T lymphoblasts,
cholesterol extraction disrupts lipid rafts that contain Lck, CD4,
and TCR but not those containing LAT.20,21 Upon TCR cross-
linking, these different rafts are thought to coalesce to facilitate
T-cell activation signaling.
The involvement of lipid rafts in LFA-1 regulation is still
controversial. LFA-1 on mouse thymocytes was shown to associate
with lipid rafts isolated with 1% Triton X-100, and cross-linking of
ganglioside GM1 with CTx induced activation of LFA-1.22 In
contrast, confocal microscopic analysis of LFA-1 transfected into
the human T-cell line Jurkat showed that LFA-1 does not associate
with rafts unless it is activated by Mn2 or the I-domain is deleted
from LFA-1.23 Shamri et al also reported that cholesterol extraction
by MCD does not inhibit LFA-1–mediated adhesion of human
peripheral blood T cells to ICAM-1.24 Thus, studies with different
cells and techniques have resulted in conﬂicting results regarding
the association of LFA-1 with lipid rafts and its functional
signiﬁcance. Here we show that cholesterol depletion or sequestra-
tion strongly inhibits LFA-1–mediated adhesion of murine T cells.
Although cholesterol is thought to be an essential component of
lipid rafts in general, our results suggest that lipid rafts of primaryT
cells are heterogeneous and some lipid rafts seem to contain little
cholesterol. LFA-1 is detected in a subset of lipid rafts that is
cholesterol rich and sensitive to MCD treatment.
Materials and methods
Cells, antibodies, and reagents
The murine T-cell leukemia line EL4 was obtained from theAmerican Type
Culture Collection (ATCC, Rockville, MD). The murine T-cell hybridoma
line T28 has been described.25 They were maintained in Dulbecco modiﬁed
Eagle medium plus 5% fetal calf serum (FCS) and penicillin/streptomycin
(StemCell Technologies, Vancouver, BC, Canada). Splenocytes were har-
vested from 6- to 8-week-old C57BL/6 mice. Splenic T cells were isolated
by murine T-cell enrichment kit, Spin Sep (StemCell Technologies), which
resulted in 98% to 99% pure T cells as assessed by ﬂuorescence-activated
cell sorter (FACS) analysis using ﬂuorescein isothiocyanate (FITC)–
conjugated anti-CD3 monoclonal antibody (mAb; BD Pharmingen, Missis-
sauga, ON, Canada). Rat anti-CD18 hybridomas (TIB213 and TIB218),
hamster anti-CD18 (2E6) hybridoma, and mouse anti–rat immunoglobulin
G (IgG) hybridoma (TIB169) were from ATCC. TIB218 was used in
Western blots to detect LFA-1 since T cells do not express other 2
integrins. Hamster antimouse CD3 antibody was purchased from BD
Pharmingen. Rat anti–Thy1 monoclonal antibody (clone 3.2) was generated
in our laboratory. Its speciﬁcity for Thy1 was conﬁrmed by the binding to
the murine lymphoma cell line S49.1 (ATCC TIB28) but not its Thy1–
negativemutantS49(Thy1-a)(ATCCTIB36).Ratanti-CD45(YE1/21.2.1)
was described previously.25 Puriﬁcation of these mAbs has been de-
scribed.26 Mouse anti-Lck (3A5) was from Santa Cruz Biotechnology
(Santa Cruz, CA) and anti–extracellular signal regulated kinase 1/2
(Erk-1/2) and anti–phospho-Erk-1/2 were from Cell Signalling Technology
(Beverly, MA). Horseradish peroxidase–conjugated CTxB, FITC-conju-
gated CTxB, MCD, ﬁlipin III, water-soluble cholesterol (MCD-cholesterol
complex), bovine serum albumin (BSA) fragment V, Triton X-100, Brij 99,
Brij 58, Brij 56, Brij 35, CHAPS (3-[(3-cholamidopropyl)dimethylammo-
nio]-1-propane-sulfonic acid), and protease inhibitors (leupeptin, phenyl-
methyl-succinyl ﬂuoride, aprotinin, and pepstatin A) were from Sigma (St
Louis, MO). Murine recombinant soluble ICAM-1 has been described.27
Calcein-AM and Alexa Fluor 568–conjugated goat anti–rat Ig were from
Molecular Probes (Eugene, OR).
Cholesterol depletion, sequestration, and reconstitution
For cholesterol depletion, cells were treated with various concentrations of
MCD in Hanks balanced salt solution (HBSS) containing 50 mM HEPES
(N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid) for 30 minutes at
37°C. For cholesterol sequestration, cells were treated with various
concentrations of ﬁlipin III in HBSS containing 0.2% BSAand incubated at
37°C for one hour. To reconstitute cholesterol of MCD-treated cells, 60
g/mLwater-soluble cholesterol in HBSS containing 0.2% BSAwas added
to the cells and incubated for 30 minutes at 37°C.
Cell adhesion assay
LFA-1–mediated cell adhesion to immobilized soluble ICAM-1 was
assayed as described.27 Brieﬂy, cells labeled with Calcein-AM were
incubated in microwells coated with soluble ICAM-1 for 30 minutes at
37°C. Nonadherent cells were washed away, and the ﬂuorescence intensi-
ties of the cells before and after the wash were measured by CytoFluor 2300
(Millipore, Bedford, MA). The percentages of cell adhesion were deter-
mined by the ratio of the postwash over prewash ﬂuorescence values after
subtracting the background ﬂuorescence values. For stimulation of LFA-1,
cells were preincubated with 50 ng/mLphorbol myristate acetate (PMA) for
30 minutes at 37°C. For speciﬁcity control, anti–LFA-1 mAb (TIB213) was
also added. For the cholesterol depletion or sequestration experiments,
MCD or ﬁlipin was added to cells as they were treated with PMA.
Sucrose gradient centrifugation and Western blotting
Cells (5 	 107) were washed twice with phosphate-buffered saline and
lysed in 1 mL ice-cold lysis buffer containing 20 mM Tris (tris(hydroxy-
methyl)aminomethane)–HCl (pH 7.2), 150 mM KCl, various concentra-
tions of nonionic detergents, and protease inhibitors. The cell lysates were
sheared by 5 successive passages through no. 26 gauge hypodermic
needles, then mixed with an equal volume of 80% sucrose (wt/vol) in
ice-cold lysis buffer without detergent, and transferred to SW41 centrifuge
tubes. The samples were then overlaid with 6 mL of 30% sucrose and 3.5
mL of 5% sucrose and centrifuged (Beckman, Palo Alto, CA) at 200 000g
for 18 hours. All of the procedures were done at 4°C. Following
centrifugation, 8 fractions of 1.5 mL each were collected, starting at the top
of the gradient. Fractions 2 and 3 corresponding to the 5% to 30% sucrose
interface were referred to as low-density fractions. Fractions 7 and 8 were
referred to as high-density fractions. The materials at the bottom of the tube
were referred to as pellet. Aliquots of each fraction were boiled in sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) sample
buffer (nonreducing condition), loaded onto SDS-PAGE, and transferred to
polyvinylidene ﬂuoride transfer membrane (Pall Gelman Lab, Ann Arbor,
MI). Proteins on the blots were detected by speciﬁc antibodies and
visualized by an enhanced chemiluminescence system (Amersham Pharma-
cia Biotech, Piscataway, NJ) according to the manufacturer’s protocols. For
mitogen-activated protein (MAP) kinase analysis, 106 cells were treated
with or without 50 ng/mL PMA and with or without 10 mM MCD for 30
minutes at 37°C, and then subjected to SDS-PAGE and Western blotting.
Flow cytometry
Cells were directly stained with the FITC-conjugated anti-CD18 mAb 2E6
(10 g/mL), FITC-CTxB (15 g/mL), or FITC-conjugated anti-CD3
(5 g/mL) for 30 minutes on ice. For the staining of CD45 and Thy1, cells
were incubated with the appropriate hybridoma supernatants for 30 minutes
on ice, washed twice, and then stained with 5 g/mL FITC-conjugated
anti–rat Ig (TIB169) mAb. The stained cells were washed with HBSS
containing 2% FCS and 0.1% sodium azide and analyzed by a FACScan
ﬂow cytometer (Becton Dickinson, San Jose, CA). For ﬁlipin staining,28
cells were treated with 12.5 g/mL fresh ﬁlipin in HBSS at 4°C in the dark
for 2 hours and analyzed by a FACStar Plus (Becton Dickinson) equipped
with a 360-nm Coherent Enterprise Argon laser (Santa Clara, CA).
Emissions were collected via a 640-nm dichroic long-pass ﬁlter with
424/44-nm band-pass ﬁlter.29,30
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T28 cell line and mouse primary T cells were stained at 4°C with
anti–LFA-1 antibody (TIB213), anti–Thy1 antibody, 15 g/mL FITC-
CTxB, and 12.5 g/mL ﬁlipin where indicated. Secondary staining for
LFA-1, Thy1, and CD45 were with Alexa Fluor 568–conjugated goat
anti–rat Ig. Capping was induced by incubation at 37°C for 30 minutes,
followed by ﬁxation with 4% formaldehyde. Cells were cytospun onto
poly-D-lysine–coated glass coverslips. Then samples were analyzed by
confocal microscope (BioRad Radiance 2000 Multiphoton; Hercules, CA)
with 	 60 objective lens. Lasers used were Kr and Mai Tai Ti Sapphire
(SpectroPhysics, Mountainview, CA). Filipin III was excited with a
multiphoton laser at 779 nm and the emission ﬁlter was HQ 450/80 with a
BGG 22 blocking ﬁlter. FITC was excited by 488 nm and the emission ﬁlter
was HQ 515/30. Alexa Fluor 568 was excited by 568 nm and the emission
ﬁlter was HQ 600/50. Signals were collected sequentially to avoid
bleed through.
Results
MCD disrupts lipid rafts and inhibits LFA-1–mediated
adhesion of T-cell lines
To determine whether lipid rafts have any role in LFA-1 activation,
the murine T-cell leukemia line EL4 and the T-cell hybridoma line
T28 were treated with MCD to remove membrane cholesterol, and
its effect on LFA-1–mediated cell adhesion to ICAM-1 (CD54) was
tested. EL4 cells showed a low level of adhesion to ICAM-1, but
upon stimulation with PMA they readily adhered to ICAM-1
immobilized on a plastic surface (Figure 1A, left panel). This
adhesion was mediated by LFA-1 as indicated by almost complete
inhibition by anti–LFA-1 mAb. MCD inhibited LFA-1–mediated
T-cell adhesion in a dose-dependent manner. MCD at these
concentrations did not cause cell death as determined by trypan
blue staining. MCD-treated cells strongly adhered to ICAM-1
when treated with 2 mM MnCl2, which binds to and directly
activates LFA-1, indicating that LFA-1 on MCD-treated cells is
potentially functional, but MCD treatment inhibits inside-out
activation of LFA-1. Similar results were obtained with T28 cells
(Figure 1A, right panel). Flow cytometric analysis of MCD-treated
cells showed that MCD had no effects on the expression levels of
LFA-1 (Figure 1B). The levels of the ganglioside GM1 and the
GPI-anchored protein Thy1, which together with cholesterol have
been considered to be components of lipid rafts, were also
unaffected by MCD treatment.
To determine whether LFA-1 on T-cell lines associates with
lipid rafts, EL4 cells were solubilized with Triton X-100 on ice and
fractionated by sucrose gradient centrifugation at 4°C. Under these
conditions, lipid rafts are detergent-insoluble and recovered in
low-density fractions (fractions 2 and 3 in Figure 1C).As expected,
GM1 and Thy1 are detected in the low-density fractions (Figure
1D). It should be noted that LFA-1 is the only 2 integrin on these
cells, and no other leukocyte integrins are detected by anti-CD18
mAb on T cells. Western blot analysis of each fraction using
anti-CD18 mAb detected no LFA-1 in the low-density fractions
when 1%Triton X-100 was used. However, when the concentration
of Triton X-100 was lowered to 0.05%, which is thought to allow
better preservation of lipid rafts,31 the majority of CD18 was
recovered in the low-density fraction (Figure 1C). Similar results
were also obtained withT28 cells (results not shown).Triton X-100
at less than 0.05% caused incomplete cell lysis and most CD18 was
found in the pellet. These results suggest that LFA-1 on these T-cell
lines associates with lipid rafts, but the association is disrupted by a
high concentration (
 0.05%) of Triton X-100.
To conﬁrm that MCD treatment disrupts lipid rafts of T-cell
lines, EL4 cells treated with MCD were analyzed by sucrose
gradient centrifugation and Western analysis. As shown in Figure
1D, all the molecules in the low-density fractions, including Thy1,
GM1, and LFA-1, were shifted to detergent-soluble high-density
fractions by MCD treatment, whereas CD45 remained in the
high-density fractions regardless of MCD treatment. The same
results were obtained with T28 cells (Figure 1D, right). Therefore,
MCD treatment indeed disrupts lipid rafts of the murineT-cell lines
EL4 and T28, and the association of LFA-1 with lipid rafts
appeared to be important for its functions.
MCD inhibits LFA-1 on primary T cells but does not disrupt
Triton X-100–insoluble lipid rafts
To extend the above ﬁndings to freshly isolated primary T cells, the
effect of MCD on LFA-1 of splenic T cells was tested. Similar to
the above results (Figure 1A) with T-cell lines, MCD inhibited
LFA-1–mediated adhesion of PMA-activated splenic T cells in a
dose-dependent manner, and the inhibition was overcome by
Figure 1. Disruption of lipid rafts and inhibition of LFA-1 activation by MCD
treatment. (A) EL4 cells (left panel) or T28 cells (right panel) were incubated with (f)
or without () 50 ng/mLPMAin the presence of the indicated concentrations of MCD
in serum-free HBSS and incubated at 37°C for 30 minutes, and their adhesion to
immobilized soluble ICAM-1 was analyzed. Cells treated with or without PMA, 10 mM
or 20 mM MCD, and 2 mM MnCl2 were also tested (shown as 10  Mn and 20  Mn).
PMA-activated cells blocked with anti–LFA-1 were tested as speciﬁcity control (u).
For control cell adhesion, BSA was immobilized in place of ICAM-1. The results are
representative of 5 independent experiments, each done in triplicate. Error bars
indicate SD. (B) Flow cytometric analysis of control () and 10 mM MCD-treated ()
EL4 cells. Ganglioside GM1 was stained with FITC-conjugated CTxB. All other
molecules were stained with the appropriate mAb with secondary FITC-conjugated
antibodies. Ctrl shows unstained control. (C) EL4 cells were solubilized with indicated
concentrations of Triton X-100 and subjected to sucrose gradient centrifugation.
Proteins in the sucrose gradient fractions were separated by SDS-PAGE, and CD18
was detected by Western blotting. Fractions 2 and 3 are low-density fractions and
contain lipid rafts, whereas fractions 5 to 8 are high-density fractions, and P indicates
pellet. (D) EL4 cells were either treated () or not () with 10 mM MCD as in panelA,
solubilized with 0.05%Triton X-100, subjected to sucrose gradient centrifugation, and
analyzed by Western blotting for the indicated molecules. The numbers indicate
sucrose gradient fractions. Fractions 2 and 3 are low-density fractions containing lipid
rafts. CD18, Thy1, and CD45 were detected by speciﬁc mAb and horseradish
peroxidase–conjugated secondary anti–rat Ig antibody. GM1 was detected by
horseradish peroxidase–conjugated CTxB.
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ﬁrmed that MCD treatment did not alter the expression levels of
LFA-1 or other molecules tested (Figure 2B). However, sucrose
gradient centrifugation analysis showed that LFA-1 on splenic T
cells differed from that on T-cell lines, as no LFA-1 on splenic T
cells was detected in the detergent-insoluble low-density fractions
isolated with 1% or 0.05% Triton X-100 (Figure 2C).Activation of
LFA-1 on primary T cells with PMA or Mn2 treatment for 30
minutes or by CD3 cross-linking for 3 days or 1 week failed to
induce association of LFA-1 with rafts (results not shown). Triton
X-100 at concentrations lower than 0.05% failed to solubilize
splenic T cells. Furthermore, quite unexpectedly, sucrose gradient
centrifugation analysis showed that the treatment of splenic T cells
with MCD did not change the distribution of any of the molecules
tested, including GM1 (83%-99% in raft fractions as measured by
densitometry) and Thy1 (100%). The Src family of protein tyrosine
kinase p56lck, which was found in rafts isolated with 0.05%, but not
with 1%, Triton X-100, remained in raft fractions with MCD
treatment. CD45 was found to be outside of rafts regardless of
Triton X-100 concentrations or MCD treatment.
Speciﬁcity of MCD treatment
The above results showed that LFA-1 on splenic T cells does not
seem to associate with lipid rafts isolated with Triton X-100, and
MCD does not seem to disrupt lipid rafts of splenic T cells.
Nevertheless, MCD treatment profoundly inhibited LFA-1–
mediated T-cell adhesion to ICAM-1. To determine whether the
effects of MCD treatment were solely due to the removal of
cholesterol from the membrane or are due to unrelated effects of
MCD, we ﬁrst conﬁrmed that MCD indeed removed cholesterol
from the membrane of T cells. Filipin III was used to stain
cholesterol of splenic T cells. Filipin is a ﬂuorescent polyene
antibiotic from Saccharomyces ﬁlipinensis, and it forms a multi-
meric globular complex with cholesterol in the cell membrane.29
Flow cytometric analysis showed that treatment of primary T cells
with MCD reduced the staining with ﬁlipin to approximately 50%
of control cells (Figure 3A), indicating that MCD indeed removed
cholesterol from the membrane of primary T cells.
If the inhibition of LFA-1 by MCD treatment was solely due to
cholesterol depletion, it should be reversed by restoring the
cholesterol level of the cell membrane.21 To test this, water-soluble
cholesterol was added to MCD-treated splenic T cells, and whether
the inhibition of LFA-1 by MCD could be reversed by cholesterol
reconstitution was examined. As seen in Figure 3B, LFA-1–
dependent adhesion of splenicTcells to ICAM-1, induced by PMA
treatment, was strongly inhibited by 10 mM MCD. Addition of
water-soluble cholesterol to MCD-treated splenic T cells effec-
tively reversed the inhibitory effects of MCD. Similar results were
also obtained with T-cell lines (data not shown).
To conﬁrm that MCD does not inhibit the intracellular signaling
induced by PMA, the effects of MCD on PMA-induced activation
of the MAP kinase pathway were tested. Phosphorylation of
ERK-1/2 was strongly induced by PMAtreatment of splenicTcells
and it was not affected by MCD treatment (Figure 3B), indicating
that the inhibitory effects of MCD on PMA-induced LFA-1
activation was not due to inhibition of PMA-induced signaling
pathways. Taken together, these results indicate that the inhibition
of LFA-1–mediated T-cell adhesion by MCD is indeed due to
depletion of cholesterol, not due to some other unrelated effects.
Filipin inhibits LFA-1 activation
Filipin, through its ability to form complexes with cholesterol, has
been used to sequester cholesterol in the plasma membrane.16 We
Figure 2. Effects of MCD treatment on primary T cells. (A) Puriﬁed splenic T cells
(
 98% CD3) were treated with the indicated concentrations of MCD, and their
adhesion to immobilized ICAM-1 was analyzed as in Figure 1A. Open bars represent
no PMA stimulation, solid bars represent PMA-stimulated (50 ng/mL) cells, and gray
bar represents PMA stimulation with anti–LFA-1 blocking antibody (TIB213). Cells
treated with 10 mM MCD and 2 mM MnCl2 (10  Mn) were included. BSA instead of
ICAM-1 was used as a control. The results are representative of 4 independent
experiments, each done in triplicate. Error bars indicate SD. (B) Puriﬁed splenic T
cells treated () or not () with 10 mM MCD were stained for the indicated
cell-surface molecules and analyzed by ﬂow cytometer as in Figure 1B. (C) Splenic T
cells were treated with () or without () 10 mM MCD, lysed with 1% or 0.05% Triton
X-100, subjected to sucrose gradient centrifugation, and indicated molecules in each
fraction were detected by Western blotting as in Figure 1D.
Figure 3. Speciﬁcity of MCD treatment. (A) Splenic T cells were treated with 10 mM MCD (ﬁlled histogram) or not (open histogram with solid line), and cholesterol in the
plasma membrane was stained with 12.5 g/mL ﬁlipin and analyzed by ﬂow cytometer. The open histogram with broken line shows autoﬂuorescence of unstained splenic
T cells. (B) Splenic T cells were treated with 10 mM MCD, and after washing away MCD, they were incubated with water-soluble cholesterol (60 g/mL) at 37°C for 30 minutes
for cholesterol reconstitution.The treated cells were analyzed for LFA-1–mediated adhesion to ICAM-1 as in Figure 1A. Open bar () indicates unstimulated cells; solid bar (f),
PMA stimulation; gray bar (u), PMA stimulation and anti–LFA-1 antibody blocking; horizontally striped bar (z), 10 mM MCD treatment after PMA stimulation; and diagonally
striped bar (o), PMA stimulation and MCD treatment followed by cholesterol reconstitution. Error bars indicate SD. (C) Splenic T cells were stimulated with () or without ()
PMAin the presence () or absence () of MCD and the phosphorylation of MAP kinase was analyzed by Western blotting using anti–phospho-ERK-1/2 antibody (top panel).
The same blot was stripped and probed with anti–ERK-1/2 antibody to conﬁrm equal loading of the samples (bottom panel).
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brane by ﬁlipin treatment has similar effects on LFA-1 as those of
cholesterol depletion by MCD treatment. Cell adhesion assays
showed that PMA-induced LFA-1 activation on EL4 cells and
splenic T cells was inhibited by ﬁlipin in a dose-dependent manner
(Figure 4A). Inhibition of LFA-1 on EL4 cells required a 4-fold
higher concentration of ﬁlipin (0.4 mg/mL versus 0.1 mg/mL) than
that for primary T cells, presumably due to a higher cholesterol
content of EL4 cells than primary T cells (Figure 5). In the range of
0.2 mg/mL to 0.4 mg/mL of ﬁlipin, the inhibition of LFA-1 was
dose dependent (data not shown). Sucrose gradient centrifugation
analysis of Triton X-100–solubilized EL4 cells showed that
cholesterol sequestration by ﬁlipin disrupted lipid rafts, and LFA-1
and Thy1 in the low-density detergent-insoluble fractions were
shifted to the high-density fractions (Figure 4B, left panel). With
primary T cells, similar to MCD treatment, ﬁlipin treatment did not
signiﬁcantly change the distribution of any of the molecules tested
(Figure 4B, right panel). These results indicate that the effects of
cholesterol sequestering by ﬁlipin are similar to those of choles-
terol depletion by MCD. In both cases, lipid rafts are disrupted only
in T-cell lines and not in primary T cells, and yet LFA-1 activation
is inhibited in both cell types.
Lipid rafts of T-cell lines and primary T cells are different
The levels of ganglioside GM1 and cholesterol of the plasma
membrane of primary T cells and T-cell lines were directly
compared. GM1 was stained with FITC-CTxB, whereas choles-
terol was stained with ﬁlipin. Flow cytometry analysis of the
stained cells showed that splenic T cells are very rich in GM1 and
have an approximately 10- to 100-fold higher level of GM1 than
T28 or EL4 cells (Figure 5). On the other hand, the level of
cholesterol in the plasma membrane of splenic T cells is nearly
10-fold lower than those of the T-cell lines.
LFA-1 in primary T cells is found in Brij 35–insoluble and
MCD-sensitive lipid rafts
The above results suggest that lipid rafts of primary T cells may
signiﬁcantly differ from those of T-cell lines, and it is possible that
LFA-1 on primary T cells may localize in lipid rafts that are soluble
in cold 0.05% Triton X-100, whereas lipid rafts of T-cell lines
containing LFA-1 are rich in cholesterol and insoluble in Triton
X-100. Therefore, we tested other nonionic detergents. Results
with CHAPS, Brij 99, Brij 58, and Brij 56 were the same as that
with Triton X-100 (data not shown). In contrast, a signiﬁcant
amount (48%-65% as measured by densitometer) of LFA-1 was
detected in the low-density fractions of sucrose gradient centrifuga-
tion when 1% Brij 35 was used to solubilize primaryTcells (Figure
6A, row 1), as conﬁrmed in 6 independent experiments. The
low-density fractions also contained GM1, Thy1, and Lck but not
CD45. Furthermore, upon treatment with 10 mM MCD to extract
cholesterol, almost 50% of LFA-1 in the low-density fractions was
shifted to the high-density fractions (Figure 6A, row 2). This result
was conﬁrmed in 3 independent experiments. Similarly, MCD
treatment reduced GM1 in the low-density fractions by approxi-
mately 10% with a corresponding increase in the high-density
fractions (Figure 6A, rows 7-8). However, the distribution of Thy1
and Lck was not signiﬁcantly disrupted by MCD treatment (Figure
6A, rows 3-6). CD45 was found outside rafts regardless of MCD
treatment (Figure 6A, rows 9-10). Filipin treatment shifted LFA-1
not only to soluble fractions but also to the pellet (Figure 6B),
possibly because of the formation of a multimeric complex of
Figure 5. Comparison of levels of GM1 and cholesterol in the plasma mem-
brane of splenic T cells and T-cell lines. Splenic T cells, EL4, and T28 cell lines
were stained with FITC-CTxB that binds to GM1 or with ﬁlipin (12.5 g/mL) that binds
to cholesterol and analyzed by ﬂow cytometer. The machine setting for the
ﬂuorescence detection was the same for all the cell types to allow direct comparison
of the expression levels. Open histograms show ﬂuorescence of unstained cells and
ﬁlled histograms show those of stained cells. The results are representative of 3
independent experiments.
Figure 4. Effects of ﬁlipin on LFA-1. (A) EL4 cells and primary T cells were
incubated with () or without () PMA in the presence of the indicated amount of
ﬁlipin, and their adhesion to immobilized ICAM-1 in the presence () or absence ()
of blocking anti–LFA-1 antibody was assessed. Error bars indicate SD. (B) EL4 cells
(left panel) and splenic T cells (right panel) were treated with () or without () 0.4
mg/mL or 0.1 mg/mL ﬁlipin, respectively, lysed with 0.05% Triton X-100, subjected to
sucrose gradient centrifugation, and indicated molecules in the sucrose gradient
were detected by Western blotting. The numbers indicate fractions starting from the
low-density fraction.
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on primary T cells indeed localizes in lipid rafts, and cholesterol
depletion with MCD or sequestration by ﬁlipin disrupts those
containing LFA-1. However, lipid rafts containing LFA-1 seem to
be different from those containing Thy1 or Lck. The former are
disrupted by MCD treatment, whereas the latter are resistant.
Experiments using Brij 35 at a concentration of 0.05% resulted in
incomplete lysis of cells, making results hard to interpret.
LFA-1 and cholesterol on primary T cells cocap
To further compare lipid rafts ofT-cell lines and primaryTcells, we
examined the codistribution of LFA-1, cholesterol, and GM1 by
confocal microscopy. LFA-1 on primary T cells and T28 cells was
cross-linked to induce capping of LFA-1, and the cells were triple
stained for LFA-1 (red), cholesterol (blue), and ganglioside GM1
(green). When capping of LFA-1 on primary T cells was induced
(Figure 7A, upper row; and 7B, row 2), cholesterol cocapped with
LFA-1, whereas GM1 was more evenly distributed on the cell
surface, suggesting that LFA-1 localizes in cholesterol-rich, but
GM1-poor, rafts. However, cholesterol-rich lipid rafts containing
LFA-1 were not totally devoid of GM1 as some GM1 colocalized
with LFA-1, resulting in yellow-white caps on the merged images.
The results shown are representative of 3 independent experiments,
in which 92  7% (n  26) of capped cells demonstrated similar
features. When the capping of the GPI-anchored protein Thy1 on
primaryTcells andT28 cells was induced, both GM1 and most, but
not all, cholesterol cocapped with Thy1 (Figure 7B-C, row 4),
suggesting that Thy1 localizes in lipid rafts that are different from
those containing LFA-1 (“Discussion”). The results were represen-
tative of 3 independent experiments in which all of the cells have
similar features (n  9). CD45 was used as a control protein that
does not localize in lipid rafts. As expected, capping of CD45 did
not induce changes in the distribution of cholesterol or GM1
(Figure 7B, row 6) in any (n  9) of the cells examined.
With T28 cells, capping of LFA-1 resulted in cocapping of both
GM1 and cholesterol (Figure 7C, row 2), indicating that lipid rafts
of T28 cells containing LFA-1 are rich in both. The results are
representatives of 3 independent experiments, in which 94  9%
(n  17) of the cells showed similar features. Thy1 similarly
cocapped with both GM1 and cholesterol (Figure 7C, row 4),
whereas no such cocapping was seen with CD45 (row 6). Confocal
microscopic analysis of EL4 cells was difﬁcult because of a very
low level of GM1 on the surface.
Discussion
We have shown here that cholesterol is important for the activation
of leukocyte integrin LFA-1. Cholesterol depletion or sequestration
by MCD or ﬁlipin treatment, respectively, results in profound
inhibition of LFA-1–mediated adhesion of T-cell lines and primary
T cells to ICAM-1. The inhibition of LFA-1 by MCD and ﬁlipin
does not seem to be due to their nonspeciﬁc effects. Pizzo et al32
reported that MCD treatment of the human T-cell line Jurkat
inhibits Ca2 release from the intracellular storage. However, the
inhibitory effects of MCD treatment in our study were reversed by
cholesterol reconstitution, and MCD treatment did not inhibit
PMA-induced MAP kinase phosphorylation. Therefore, the inhibi-
tion of LFA-1 by MCD is most probably due to depletion of
cholesterol, not due to unrelated nonspeciﬁc effects.
Figure 7. Confocal microscopic analysis of cocapping of LFA-1 and choles-
terol. (A) Splenic T cells (upper row) and T28 cells (lower row) were stained with
anti–LFA-1 and Alexa Fluor 568–conjugated goat anti-rat secondary antibody (red)
and incubated at 37°C for 30 minutes to induce capping of LFA-1.The cells were then
stained at 4°C for cholesterol with ﬁlipin (blue) and for GM1 with FITC-CTxB (green),
ﬁxed with formaldehyde, and analyzed by confocal microscopy. Images of midlevel
sections of the cells are shown. Merge images are shown in the right-most columns.
Results are representatives of multiple cells in 3 independent experiments.
(B) Primary T cells were either untreated (rows 1, 3, and 5) or subjected to antibody
cross-linking to induce capping of LFA-1 (row 2), Thy1 (row 4), or CD45 (row 6). The
cells were then stained in 3 colors for cholesterol (blue), GM1 (green), and either
LFA-1, Thy1, or CD45 (red) and analyzed by confocal microscopy as in panel A.
(C) The T28 cell line was analyzed as in panel B. The images were captured with a
	 60 objective lens, and the ﬁnal magniﬁcations in the ﬁgure are approximately
	 1000 for primary T cells and 	 500 for T28.
Figure 6. Detection of LFA-1 in Brij 35–insoluble, MCD- and ﬁlipin-sensitive
lipid rafts of primary T cells. (A) Primary T cells, untreated () or treated () with
10 mM MCD, were solubilized with 1% Brij 35 and subjected to sucrose gradient
centrifugation. Fractions were blotted with corresponding antibodies. (B) Primary
T cells were either untreated () or treated () with 0.1 mg/mL ﬁlipin, lysed with 1%
Brij 35, subjected to sucrose gradient centrifugation, and fractions were probed with
anti-CD18 (LFA-1). The results are representative of 3 independent experiments.
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disrupts lipid rafts in general.16 However, our current results
showed that lipid rafts of T cells are heterogeneous and not all of
them are disrupted by cholesterol depletion. Those isolated from
primary T cells with Triton X-100 are not disrupted by MCD or
ﬁlipin treatment. In contrast, lipid rafts isolated fromT-cell lines by
the same procedure are sensitive to MCD or ﬁlipin. Furthermore,
LFA-1 is detected in lipid rafts isolated with 0.05% Triton X-100
for T-cell lines or with 1% Brij 35 for primary T cells. Importantly,
cholesterol depletion with MCD disrupted lipid rafts that contain
LFA-1 in both cases. Thus, it seems likely that the inhibition of
LFA-1–mediated T-cell adhesion to ICAM-1 by MCD or ﬁlipin
treatment is due to disruption of lipid rafts containing LFA-1.
However, it should be noted that a substantial portion of LFA-1 on
primary T cells is found in nonraft fractions, and MCD treatment
reduces the amount of LFA-1 in lipid rafts and cholesterol in the
plasma membrane only by about 50%. Nevertheless, the same
MCD treatment almost completely inhibits LFA-1–mediated T-cell
adhesion. It is possible that the density of LFA-1 or cholesterol in
lipid rafts may have to exceed a critical threshold for the activation
of LFA-1, and the treatment with MCD may lower the levels of
LFA-1 and/or cholesterol in lipid rafts below the threshold. The
precise role of lipid rafts in the regulation of LFA-1 remains to be
determined. It is possible that lipid rafts may fuse to form larger
rafts upon cell activation and induce clustering of LFA-1, which
enhances avidity of LFA-1. Cholesterol may mediate lipid raft
association of LFA-1, and dissociating LFA-1 from rafts may
impair its ability to cluster and hence disturb its avidity.
Our results have demonstrated signiﬁcant differences between
primaryTcells andT-cell lines. PrimaryTcells are rich in GM1 but
have only a small amount of cholesterol, whereas T-cell lines have
high levels of cholesterol and a relatively low amount of GM1.
Tuosto et al have reported that GM1 in resting human peripheral
blood T cells is stored in the intracellular compartment and
mobilized to the cell surface upon cell activation.33 Therefore, we
tested the level of GM1 in murine splenic and peripheral blood T
cells by cell-surface staining of intact cells as well as intracellular
staining of permeabilized and ﬁxed cells with FITC-CTxB. Confo-
cal microscopy of the unﬁxed cells showed that both splenic and
peripheral blood T cells expressed a high level of GM1 on the cell
surface, and the expression level did not change upon activation
with concanavalinA.When the cells were ﬁxed with paraformalde-
hyde and permeabilized with Triton X as described by Tuosto et
al,33 all of the cell-surface staining was lost, leaving only weak
intracellular staining (results not shown). Therefore, we were
unable to properly examine intracellular GM1. Lipid rafts of
primary T cells seem to be rather heterogeneous with respect to
their lipid and protein compositions. Most of them seem to consist
mainly of GM1 and perhaps only a small amount of cholesterol.
They are insoluble in Triton X-100 or Brij 35 and are resistant to
cholesterol depletion because of low cholesterol content, and they
contain Thy1 and Lck but not LFA-1. However, some lipid rafts of
primary T cells seem to contain a higher amount of cholesterol and
only a small amount of GM1. These cholesterol-rich lipid rafts
contain LFA-1 but not Thy1 or Lck, and they are sensitive to
cholesterol depletion. They are also insoluble in Brij 35 but not
other detergents tested in our study, including Triton X-100,
CHAPS, Brij 99, Brij 98, Brij 58, and Brij 56. On the other hand,
lipid rafts of T-cell lines seem to have a higher amount of
cholesterol and substantially less GM1 and they contain LFA-1,
Thy1, and Lck. They are mostly insoluble in Triton X-100 and
sensitive to MCD or ﬁlipin. Sphingolipids have long saturated acyl
chains and are thought to be critical for the formation of a
liquid-ordered phase of lipid rafts.31,34,35 Ganglioside-rich mem-
brane microdomains are not disrupted by MCD treatment.36 The
existence of a glycosphingolipid core rich in ganglioside GM1 and
GPI-anchored proteins and resistant to Triton X-100 treatment has
also been suggested.37,38 Our ﬁnding that the membranes of
primary T cells are rich in GM1 and resistant to cholesterol
depletion is consistent with this idea. In contrast to primary T cells,
T-cell lines have high levels of cholesterol, and their lipid rafts are
susceptible to disruption by MCD or ﬁlipin treatment. Results from
confocal microscopy also support the idea of the existence of
heterogeneous lipid rafts in primary T cells. LFA-1 cocaps with
cholesterol but not with GM1 suggesting that LFA-1 is associated
with cholesterol-rich, but low in GM1, lipid rafts. GPI-anchored
Thy1 cocaps with both GM-1 and cholesterol, suggesting thatThy1
localizes in lipid rafts containing both.
Based on our current results, we propose a model for lipid raft
heterogeneity in primary T cells (Figure 8), where different rafts
are not distinctly separated, but rather exist as a continuous
spectrum, ranging from those consisting of mostly GM1 to those of
mostly cholesterol. The range of lipid rafts that remains cold
detergent–insoluble depends on the detergent.Amuch wider range
of lipid rafts seems to be insoluble in Brij 35 than in Triton X-100
or other detergents. This model explains why cholesterol, but not
most GM1, cocaps with LFA-1, whereas some, but not all,
cholesterol and GM1 cocaps with Thy1. The model predicts that
the sensitivity of lipid rafts to MCD treatment depends on the
cholesterol content of the rafts. In primary T cells, which have a
relatively low level of cholesterol, only those with the highest level
of cholesterol are MCD sensitive, and LFA-1 seems to be
associated with these lipid rafts.
The role of lipid rafts in LFA-1 regulation has been controver-
sial. Krauss and Altevogt reported that LFA-1 on mouse thymo-
cytes is found in lipid rafts isolated with 1% Triton X-100.22
However, we failed to detect a signiﬁcant amount of LFA-1 in lipid
rafts isolated from murine thymocytes with 1% or 0.05% Triton
X-100 (data not shown). It is possible that only a very small
proportion of total LFA-1 on thymocytes is in lipid rafts. Leitinger
and Hogg reported that LFA-1 transfected into the human T-cell
line Jurkat did not localize in lipid rafts unless it was activated by
Mn2 or its I-domain was deleted.23As shown in our current study,
T-cell lines and primaryTcells signiﬁcantly differ in lipid rafts, and
ﬁndings with T-cell lines do not necessarily apply to primary T
cells. Shamri et al reported that MCD did not inhibit LFA-1–
mediated adhesion of chemokine-stimulated human peripheral
bloodTcells to ICAM-1,24 whereas MCD strongly inhibited LFA-1
activation with PMAin our study.This may be due to differences in
theinside-outsignalingpathwaysinvolvedinPMA-andchemokine-
induced activation of LFA-1.
Figure 8. A model for lipid raft heterogeneity in primary T cells. The solid line
represents GM1 content of lipid rafts, and the thick dashed line represents cholesterol
content.Thy1 and Lck localize in GM1-rich lipid rafts (darker gray bar), while LFA-1 partially
localizes in cholesterol-rich rafts (lighter gray bar). Thick black bars represent lipid raft
insolubility in Triton X-100 (1% and 0.05%) and Brij 35 (1%). MCD sensitive bar shows the
portion of lipid rafts that is insoluble in 1% Brij 35 and sensitive to MCD treatment.
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be important for the formation of immunologic synapse between T
cells and antigen-presenting cells.4 LFA-1 on T cells has been
shown to initially form a cluster in the center of a T-cell/antigen-
presenting cell contact point and subsequently move to the
periphery, forming a ring around the central core of the TCR
cluster.5,6 Since many intracellular signaling molecules involved in
TCR-mediated signaling are thought to associate with lipid rafts, it
is speculated that lipid rafts may play an active role in the formation
of immunologic synapse. Our results suggest that in primary T
cells, LFA-1 and Lck may associate with different subsets of lipid
rafts. This may explain why in immunologic synapse formation
LFA-1 is found in the periphery supramolecular activation com-
plexes (SMAC), while TCRs and Lck are in the center SMAC.5,6
Recently it has been demonstrated that GM1 accumulates in the
center SMAC and it is resistant to MCD treatment, whereas
peripheral SMAC, which contains LFA-1, seems to be sensitive to
MCD treatment.39 These results further supported the idea of lipid
raft heterogeneity and its involvement in immunologic synapse.
Taken together with our data, we predict that cholesterol accumu-
lates in peripheral SMAC. The relationship between distributions
of LFA-1, cholesterol, lipid rafts, and immunologic synapse
requires further investigation. The results presented in this report
have important implications to the studies on lipid rafts ofTcells in
general. We have demonstrated that lipid rafts of primary T cells
are quite different from those of T-cell lines. Therefore, many
studies on lipid rafts using T-cell lines will have to be re-examined
with primary T cells.
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